![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2021/04/15/2210630/11011/en/COVIS-PHARMA-GROUP-Announces-Top-line-Safety-and-Efficacy-Data-from-a-Phase-3-Placebo-Controlled-COVID-19-Study-Using-Inhaled-Corticosteroid-ciclesonide.html
https://www.prnewswire.com/news-releases/covis-pharma-bv-initiates-phase-3-clinical-trial-of-alvesco-ciclesonide-inhaler-for-the-treatment-of-covid-19-301061105.html
https://www.fiercepharma.com/pharma/astrazeneca-sells-u-s-canada-seroquel-rights-to-cheplapharm-for-up-to-42m
https://www.ema.europa.eu/en/news/committee-medicinal-products-veterinary-use-cvmp-meeting-5-7-november-2019
http://www.businesswire.com/news/home/20150127005166/en/PsychoGenics-Achieves-Milestone-Drug-Discovery-Collaboration-Sunovion#.VMiRcdKUdqU